Abstract
In all reported clinical studies with <sup>18</sup>F-FDG–labeled leukocytes, heparin was used as an anticoagulant during labeling. Theoretically, the substitution of heparin with citrate should be advantageous. <b>Methods:</b> Blood from healthy...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have